ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,233Top JournalHybrid

European Journal of Nuclear Medicine and Molecular Imaging

Acronym:ejnm
•
Abbreviation (ISO):EUR. J. NUCL. MED. MOL. IMAGING
•
Identifier (ISSN):1619-7070(Print)/1619-7089(Online)
•
Publisher:Springer Berlin Heidelberg
Clarivate IF (2026)
7.6– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Nuclear Medicine and Molecular Imaging

WoS Q1
4710137.720187.1820197.0820209.24202110.120229.120238.620247.620257.62026
Annual Impact Factor Metric
Current (2026):7.6
Scopus SJR & RankScopus Q1
2.167
#1,233

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
200

200 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate9.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
370articles/year
47.15% Gold OA•92.45% Original Research

Aims & Scope

The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies. The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published. The journal publishes the following article types: Original article, Review article, Letter to the Editor, Guidelines, Controversies, Image of the month, Short Communications, Editorials

Topics Covered (Recognized by AI)
Medicine98.1%Biology78.1%Internal medicine74.4%Nuclear medicine72.6%Radiology64.4%Psychology51.2%Genetics50.9%Pathology42.9%Neuroscience41.5%Physics36.6%Surgery36.5%Chemistry34.8%Positron emission tomography33.6%Biochemistry25.2%Endocrinology22.9%Cancer22.8%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q1
Rank12/217
IndexSCIE
JCISCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q1
Rank10/217
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.6
Articles / Year481
Total Citations205
2025
IF7.6
Articles / Year665
Total Citations2,794
2024
IF8.6
Articles / Year466
Total Citations4,956
2023
IF9.1
Articles / Year488
Total Citations8,424
2022
IF10.057
Articles / Year435
Total Citations12,299

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,233Scopus Q1SCImago Profile
Scopus Coverage:1996-1997, 1999, 2001-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
2.167

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.85

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,846 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,433
3-Year Documents1,316
Citable Documents1,022

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate39.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Radiology, Nuclear Medicine and ImagingQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 9.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Nuclear Medicine and Molecular Imaging (acronym: ejnm, abbr: EUR. J. NUCL. MED. MOL. IMAGING, ISSN: 1619-7070) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in Germany since 1976. The periodical holds a Journal Impact Factor (JIF) of 7.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.167 (Q1), an H-index of 200.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 370 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,846 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Berlin Heidelberg
Publication Language
English
Frequency
Monthly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: dfdd861f-3dce-4dca-a1a8-9f8cd56ba0ec
Database Updated: 2026-09-28